Skip to content

Redwire RDW Property, plant, and equipment additions

Property, plant, and equipment additions at other companies

West Pharmaceutical Services logo
West Pharmaceutical ServicesWST

Segments

By segment

See full
Defense Tech$3.95M+3,853%
Space$597K-68.0%

Other financials

Income statement

See full
Revenue$97.0M+57.9%
Gross profit$25.8M+185%
Operating income-$69.7M-387%
Net income-$76.5M-2,495%
EPS (diluted)-$0.40-344%

Balance sheet

See full
Cash & equivalents$145.2M+168%
Total debt$128.7M+2.6%
Total equity$1.1B+1,698%
Total assets$1.5B+381%

Cash flow

See full
Operating cash flow-$6.7M+85.2%
CapEx$4.8M+166%
Free cash flow-$11.4M+75.6%

Valuation

See full
Market cap$2.43B+155%
Enterprise value$2.41B+127%
P/S6.6×+3.1×

Profitability

See full
Gross margin9.2%-4.7pp
Operating margin-76.8%-115pp
Net margin-80.9%-1,477pp
FCF margin-41.9%

Returns & leverage

See full
Return on equity-254.4%-886pp
Debt / equity0.1×
Current ratio1.8×+0.6×